Danone’s CMO, which adapts advertising with GLP-1, improves the food industry.

This audio is automatically created. Please let me know if there is feedback.

The GLP-1 drug market is estimated to have more than $ 100 billion in annual sales in the next decade. However, the drug category, which was first developed for diabetes but is currently widely used for weight loss, has also begun to affect the food and beverage industry, which requires diets that require diets that are rich in protein and nutritious diet.

In the case of Danone, Danone North American CMO Linda Betea, a brand marketing manager, including the Oikos Greek Yogurt and Dairy Dairy Silk, is one way to manufacture the product mixed for GLP-1 drugs. Danone North American CMO Linda Betea said, “It is another thing to communicate to meet this changing consumer base, according to Danone North America CMO Linda Betea.

CMO Linda Bethea's Danone

CMO Linda Bethea’s Danone

Danone provided

“We have seen the increase in consumer interest in health and health since Covid. They are more interested in high protein products, high textile products, author products, and convenience.” “This has been accelerated by the adoption of diabetes and aviation drugs. Those who take GLP-1 drugs have different nutritional demands, and our portfolio is in a position to convey well to those (necessary).”

To better meet the developing consumer demands, Danone has tested an advertising campaign running on the Pinterest and on -site displays with a diet -oriented messaging. The marketing manager also encouraged the FDA to make the first qualified health claim for yogurt. Information shared when a consumer shopping in Target, Amazon or Walmart for Danone yogurt.

Marketing diving talked with Bethea about how these AD experiments and marketing staff approached their retail media networks, artificial intelligence (AI) and Super Bowl ads.

The following interviews were edited for clarity and simplicity.

Marketing Diving: How does Danone adjust the portfolio’s marketing to meet consumer changes, such as increasing interest in GLP-1 support diet?

Linda Bethea: Everything returns from Danone for our purpose. We start by verifying that we are leading to health -oriented portfolios because we have a mission to provide health through food to many people as much as possible. 70 %of our portfolios are highly dense and can be delivered to this evolving consumer needs. But through this extensive portfolio we need to make each brand offer in a suitable way for that brand.

For example, Oikos is a high -protein brand in yogurt portfolio. Protein consumption is most interested in consumers. 71% of adults are interested in increasing the amount of protein in diets, and we are focusing on protein -led messages with Oikos and increased 40% last year. We know that we know that we increase the amount of vegetable products in consumer diets, so we can lean with silk and try to focus on the advantages of the plants throughout the silk portfolio. (We) In a way to reach our most important Danone mission, which is faithful to the meaning of each brand, but provides health through food.

How is Danone bringing life to these brand messages?

All our marketing media strategies actually try to convey the right message to the right consumers. We were really important to understand consumer trips in health-centered messaging, especially in the GLP-1 space. Did they first learn about GLP-1 drugs? Whose information did you get information, whether you are a medical professional or an online influence?

We absolutely implement testing and learning culture before expanding marketing initiatives. We tested advertisements at Pinterest. Here people knew that they would search for nutrition and recipes. We have partnerships with some major retailers to perform on-site retail media and test the most messaging of protein lead messaging, GLP-1-lead messaging, and nutrient syringe messaging.

What is the health -related channel you are using?

We tested messaging through the patient portal of the doctor’s office. This is a good opportunity for people to communicate the right type of message because people are the core places for GLP-1 drugs. I have a great learning about resonating with consumers and I am absolutely looking for information about nutrients needed for GLP-1 drugs.

We know how GLP-1 drugs work, and we are reducing consumption all day long, so it is more important to have a nutritional density to meet the needs of nutrients. It can be difficult for consumers to do in areas without knowledge. Danone has a lot of registered nutritionists, and we have partnered with registered nutritionists in the community to provide the information.